HOME >> MEDICINE >> NEWS
New study shows antibiotic treatment does not reduce risk of secondary cardiac events

s against the C. pneumoniae bacteria and for its once-weekly dosing.

ACES enrolled men and women at 28 centers across the country between 1999 and 2000. Pfizer, Inc., co-sponsored the study and supplied study medications.

"Although antibiotic treatment of patients with clinical coronary heart disease is not helpful, the ACES study was not designed to find the role of C. pneumoniae in the cause or progression of coronary heart disease. Different studies will be needed to determine the role of C. pneumoniae in the early, asymptomatic development of coronary heart disease," said J. Thomas Grayston, M.D, Professor of Epidemiology, University of Washington, Seattle, the study's principal investigator.

The ACES results are confirmed and extended by the similarly negative findings of the PROVE-IT trial published in the same issue of the New England Journal of Medicine. PROVE-IT tested a different antibiotic, a fluoroquinolone, and used a different treatment schedule with participants who were somewhat younger than those in ACES and who had an acute cardiac event at time of their enrollment in the study.


'"/>

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
20-Apr-2005


Page: 1 2

Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. New study counts the economic cost of persistent pain in Australia
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Most seniors now have drug coverage, U-M study shows
7. To gain muscle and lose fat, drink milk: study
8. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
9. Even older women at high risk have little interest in being tested for HIV, study finds
10. Metabolic study in mice could lead to good cholesterol boosters
11. Michigan-CDC study supports value of social restrictions during influenza pandemics

Post Your Comments:
(Date:5/23/2013)... Elegance for a woman takes on so many ... her intrigue can often be found in the mystery of her ... soul is through her eyes. It is also true that ... is why the elegance of a woman can be found in ... more than any other time, utilize eyewear to not only compliment ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 A new ... benefits in Florida’s Medicaid program could save $2.1 billion ... receive. The new report shows that Florida and other ... tools Medicare, unions, and employers rely on to curb ... study and Medicaid pharmacy at MedicaidPharmacySavings.com . , ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Maintaining ... today launches its Summer Health Campaign. Kicking off in ... to offering a luxury bed for everyone and to ... overall health and well-being. , May is Better Sleep ... by the Better Sleep Council due to the Centers ...
(Date:5/23/2013)... May 2013.- CNIC researchers have discovered that the daily ... of hematopoietic stem cells from the bone marrow into ... the journal Cell ., Neutrophils are leukocytes (white ... bacteria and other disease organisms. To perform their function, ... contact with microorganisms. However, release of these substances in ...
(Date:5/23/2013)... May 23, 2013 Diabetes is one ... can become a nuisance when patients are unfortunate enough ... to the National Diabetes Information Clearinghouse at http://goo.gl/QyhCz ... a risk of developing neuropathy which further shrivels the ... of such patients. Such nerve damage affects the whole ...
Breaking Medicine News(10 mins):Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion 2Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2
(Date:5/22/2013)... , May 22, 2013  Aribex, Inc., manufacturer of ... today introduced a new color option, black with gray ... dental and veterinary markets. The popular white with light ... will continue to be available and both models can ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental ...
(Date:5/22/2013)... Calif. , May 22, 2013 Advanced ... a medical device that will help alleviate the high ... targeted apheresis cartridge is expected to be the first ... cause of maternal and fetal death. Every ... the United States . It is characterized ...
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World ... aligned with the latest trends and events, companies ... can predict where an industry is headed next, ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... with market research publisher GlobalData, offer decision makers ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4
Cached News: